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Abstract The present study aims at determining the
structure-activity relationships (SAR’s) ruling the biological
function of MGBG (methylglyoxal bis(guanylhydrazone)),
a competitive inhibitor of S-adenosyl-L-methionine decar-
boxylase displaying anticancer activity, involved in the
biosynthesis of the naturally occurring polyamines spermi-
dine and spermine. In order to properly understand its
biochemical activity, MGBG’s structural preferences at
physiological conditions were ascertained, by quantum
mechanical (DFT) calculations.
Keywords MGBG  SAMDC  Structure-activity
relationships  DFT calculations  Physiological structures 
Mitochondrial permeability transition (MPT)
Abbreviations
CsA Cyclosporin A
DW Electrical membrane potential
DFT Density functional theory
FCCP Carbonyl cyanide-p-trifluorometoxyphenyl-
hydrazone
MGBG Methylglyoxal bis(guanylhydrazone)
MPT Mitochondrial permeability transition
PCM Polarised continuum model
RLM Rat liver mitochondria
SAMDC S-Adenosyl-L-methionine decarboxylase
SCRF Self-consistent reaction field
SD Standard deviation
SSAT Spermidine–spermine acetyltranferase
TPP+ Tetraphenylphosphonium cation
Introduction
Methylglyoxal bis(guanylhydrazone) (MGBG, Fig. 1) is a
polycation (at physiological conditions) containing two
guanidinium groups, which acts as a competitive inhibitor
of S-adenosyl-L-methionine decarboxylase (SAMDC)
(Wallace and Fraser 2004), being thus involved in the
biosynthesis of the biogenic polyamines spermidine and
spermine. During the 1960s it garnered a considerable
interest for its antineoplastic and strong cytotoxic effects
(Mihich 1963), but it was discarded from therapeutical use
due to its severe toxicity. However, subsequent clinical
investigations have shown that particular administration
conditions strongly reduce MGBG’s toxicity while pre-
serving its antitumoural action (Von Hoff 1994).
Although the mechanisms underlying the antiprolifera-
tive and cytotoxic effects of MGBG are still not well
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understood, they are probably linked to the production of
reactive oxygen species upon MGBG oxidation (which,
however, has not been proved), as well as to its interaction
with polyamine metabolism and mitochondrial function. In
fact, biogenic polyamine metabolism is one of the main
targets of MGBG, which reduces the intracellular poly-
amine content through induction of spermidine–spermine
acetyltransferase (SSAT) (involved in polyamine catabo-
lism) (Regenass et al. 1992) and inhibition of SAMDC
(essential for polyamine synthesis) (Williams-Ashman and
Schenone 1972). Again polyamine oxidation represents a
crucial catabolic pathway in polyamine metabolism by
which these polycations can be involved in oxidative stress
and apoptosis (Agostinelli et al. 2004). In this regard, it has
been reported that MGBG is able to inhibit polyamine
oxidase activity in thymus suggesting a positive role for
this drug in HIV related diseases (Ferioli and Armanni
2003). Furthermore, some reported studies evidence an
increased MGBG antitumour activity in malnourished
patients, possibly due to their low intracellular polyamine
pool (Von Hoff 1994).
At the mitochondrial level, MGBG exhibits inhibition of
protein phosphorylation (Gosalvez et al. 1974; Mailer and
Petering 1976; Muhammed et al. 1983; Warrell and Bur-
chenal 1983), impairment of carnitine palmitoyl tranferase
and carnitine acetyl transferase (Nikula et al. 1985; Brady
et al. 1987), and an overall damaging effect due to selective
inhibition of mitochondrial DNA synthesis (Feuerstein
et al. 1979). Reported studies on Ehrlich ascites carcinoma
cells suggest that the precursor of MGBG, methylglyoxal,
induces cytotoxicity by inhibiting the electron flux along
Complex I of the mitochondrial respiratory chain (Ray
et al. 1994). In isolated rat liver mitochondria (RLM),
MGBG was found to display an inhibitory effect towards
Ca2+-induced permeability transition in the presence of
phosphate and oxalacetate (Toninello et al. 1988), similarly
to what is known to occur in the presence of spermine and
spermidine (Lapidus and Sokolove 1994; Tassani et al.
1995). In this regard, it should be emphasised that MGBG
binding to the mitochondria membrane, at the site
responsible for polyamine transport, must be excluded,
according to the particular structural characteristics of both
the receptors and MGBG (Dalla Via et al. 1999; Toninello
et al. 1999). This leads to the conclusion that MGBG’s
inhibitory effect on polyamine binding to membranes
probably arises from conformational changes at the
receptor, induced upon binding of the drug to a neigh-
bouring site(s) (Toninello et al. 1999) (in accordance with
the induced-fit theory of drug-receptor interaction). The
mechanism (or mechanisms) associated to MGBG trans-
port in mitochondria is still not known, nor that associated
to its inhibition of mitochondrial permeability transition
(MPT) induction.
The biochemical properties of polyamines and related
compounds are recognizedly dependent on their geomet-
rical characteristics, at the molecular level. In order to
establish the relationship between the structural prefer-
ences of MGBG and its biological action—in particular its
transport mechanism(s), binding to macromolecular struc-
tures and MPT prevention—a conformational analysis in
aqueous solution, as a function of pH, was carried out
through theoretical methods. The results obtained agree
well with a previous study carried out for the biogenic
amine agmatine, which also contains a guanidinium moi-
ety, known to be essential for the activity of this kind of
polyamines (Toninello et al. 2006).
Materials and methods
Chemicals
[14C]-MGBG and [14C] spermidine were purchased from
Amersham Int. (Buchinghamshire, England), while [14C]-
arginine was obtained from NEN (Boston, MA, USA).
[14C]-agmatine was prepared by treating [14C]-arginine
Fig. 1 Schematic
representation of the calculated
(PCM/B3LYP/6-31G**) lowest
energy geometry for
diprotonated MGBG,
comprising the most relevant
atomic charges and the
(N)HO(H) interactions with
the solvent (water) molecules
(The atom numbering is
included)
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with Escherichia coli arginine decarboxylase, as reported
in (Cabella et al. 2001). Hepes, EGTA and rotenone were
purchased from Sigma-Aldrich. Cyclosporin A was kindly
provided by Sandoz Pharma, Basel (Switzerland). All other
reagents were of the highest quality available.
Quantum mechanical calculations
The quantum mechanical calculations—full geometry
optimisation and calculation of the harmonic vibrational
frequencies—were performed using the GAUSSIAN 03W
program (Frisch et al. 1998) within the density functional
theory (DFT) approach, in order to properly describe the
electron correlation effects (particularly important in this
kind of nitrogen-containing systems). The widely
employed hybrid method denoted by B3LYP (Cotton and
Feng 1998; Wagener and Frenking 1998), which includes a
mixture of Hartree-Foch and DFT exchange terms and the
gradient-corrected correlation functional of Lee, Yang and
Parr (Lee et al. 1988; Miehlich et al. 1989), as proposed
and parametrised by Becke (1988, 1993), was used, along
with the double-zeta split valence basis set 6-31G**
(Hariharan and Pople 1973; Francl et al. 1982).
Molecular geometries were fully optimised by the Berny
algorithm, using redundant internal coordinates (Peng et al.
1996): the bond lengths to within ca. 0.1 pm and the bond
angles to within ca. 0.1. The final root-mean-square (rms)
gradients were always less than 3 9 10-4 hartree bohr-1
or hartree radian-1. No geometrical constraints were
imposed on the molecules under study.
The solvent effect (water) was simulated by performing
Self-Consistent Reaction Field (SCRF) calculations, using
Tomasi´s Polarised Continuum Model (PCM) (Barone et al.
1998; Cammi and Tomasi 1995; Miertus et al. 1981). This
approach defines the molecular cavity as the union of a
series of interlocking spheres centered on the distinct atoms
of the system. A dielectric constant of 78.39 was used for
water. Moreover, two water molecules were explicitly
considered in the calculations, in order to account for the
(N)HO(H) interactions between MGBG and the solvent,
which are of the utmost importance for an accurate repre-
sentation of this kind of systems under physiological
conditions.
Harmonic frequency calculations were performed for all
the lowest energy conformations, at the PCM/B3LYP/6-
31G** level, in view of determining if these were real
minima in the potential energy surface (conformers).
Mulliken atomic charges and total dipole moments were
obtained for the different MGBG conformers. The relative
populations were determined according to the Boltzmann
distribution (at 25 and 37C), based on the relative
conformational energies yielded by the geometry optimi-
sation process.
Biochemical assays
Hepatocytes were prepared from male Wistar rats
(weighing 150–200 g) by the collagenase perfusion
method (Probst and Unthan-Fechner 1985) and cultured as
reported by Cabella et al. (2001), using M199 medium
supplemented with 2 mg/ml bovine serum albumin
(BSA), 3.6 mg/ml Hepes, 100 U/ml penicillin, 100 lg/ml
streptomycin, 5% horse serum and 1 nmol/ml insulin.
After 48 h, the medium was removed, the cells were
washed once with 0.8% NaCl, 0.02% KCl, 0.115%
Na2HPO4 and 0.02% KH2PO4 pH 7.2, and suspended in
2 ml of Earl’s balanced salt solution with both labeled
MGBG, or agmatine. After further incubations at different
times, the medium was removed and the cells were
washed three times with ice-cold NaCl/phosphate, and
frozen at -80C. MGBG and agmatine uptake were
measured after solubilisation of each sample in 1 ml of
0.2 M HClO4 and centrifuging at 50,000g for 15 min,
followed by total radioactivity counting of the supernatant
by liquid scintillation. Cell proteins were determined in
the 1 M NaOH solubilised pellet, as described by Brad-
ford (1976).
RLM were isolated in 0.25 M sucrose and 5 mM Hepes
(pH 7.4) by conventional differential centrifugation
(Schneider and Hogeboom 1950). Mitochondrial protein
concentration was assayed by the biuret method, using
BSA as a standard (Gornall et al. 1949). Mitochondrial
incubations were carried out at 20C, with 1 mg of mito-
chondrial protein/ml in the following standard: medium
250 mM sucrose, 10 mM Hepes (pH 7.4), 5 mM Na-
succinate and 1.25 lM rotenone. A sucrose-based medium
was chosen, in order to compare the results with those
obtained in polyamine transport studies (for a review see
Toninello et al. 2004). [14C]MGBG, [14C]agmatine and
[14C]spermidine uptake was determined by a centrifugal
filtration method (Toninello et al. 1985).
Mitochondrial membrane potential (DW) values were
calculated on the basis of the distribution of the lipid-
soluble tetraphenylphosphonium cation (TPP+) through the
inner membrane, measured on a home-made TPP+-specific
electrode (Kamo et al. 1979). Mitochondrial matrix volume
was calculated from the distribution of [14C]sucrose and
3H2O (Palmieri and Klingenberg 1979).
Mitochondrial swelling was evaluated by the apparent
absorbance change of mitochondrial suspensions, measured
at 540 nm on a Kontron Uvikon 922 spectrophotometer
equipped with thermostatic control.
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Results and discussion
Quantum mechanical calculations
A complete geometry optimisation was carried out for
MGBG in aqueous solution, considering its different pro-
tonation states, with particular emphasis on the diprotonated
form (H2MGBG), which is the major species under physi-
ological conditions (pKa (MGBG) = 7.5 and 9.2; William-
Ashman and Seidenfeld 1986).
Five populated conformers (at room temperature) were
obtained for dicationic H2MGBG (Table 1), from which
only three have a population (at 37C) higher than 1%—
MGBG 21, MGBG 22 and MGBG 23 (Fig. 2). The most
stable geometry MGBG 21, largely predominant at 25C,
displays a coplanar structure and a trans orientation of the
two (C=)NH groups relative to the NH3
+ moieties. Also,
internal rotation around the C1–N5, C13–N12 and C9–C10
bonds lead to a distinct orientation of the methyl group (in
C21) relative to the main carbon chain of the molecule, the
lowest energy geometries being those for which C21H3 and
the N2H3 terminal are in a syn orientation—MGBG 21,
MGBG 22 and MGBG 23 species. Actually, the two less
stable conformers MGBG 24 and MGBG 25 differ from
these only in the relative position of the CH3 and NH3
+
groups. MGBG 24, however, displays a quite high dipole
moment as compared to the other dicationic species
Table 1 Calculated relative energies, populations and dipole
moments (l) for the distinct conformers of diprotonated MGBG (in
aqueous solution)
Conformer DE/kJ mol-1 Populationa (%) l/Db
MGBG 21 0 95.7 1.3
MGBG 22 10.0 1.7 3.5
MGBG 23 10.4 1.5 3.0
MGBG 24 11.7 0.8 9.5
MGBG 25 14.5 0.3 7.1
a Calculated at 37C
b 1 D = 1/3 9 10-2 Cm
Fig. 2 Schematic
representation of the calculated
lowest energy conformers for
the diprotonated form of MGBG
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(Table 1), which may be responsible for an increase of its
in vivo population.
Similarly to reported results on the biogenic amine
agmatine (Toninello et al. 2006), which contains one NH3
+
terminal and a guanidinium moiety, a trans localisation of
the two imino NH’s relative to the NH3
+ groups (MGBG
21) is preferred over a cis orientation. In fact, the confor-
mation of the guanidinium group ((C1=)N–H) presently
obtained for the most stable MGBG geometry—trans rel-
ative to the C1–N2 bond—is identical to the one previously
obtained for agmatine (Fig. 3). This is easily understand-
able for the N-protonated species investigated, in the light
of minimisation of the H3H7 and H15H18 steric repul-
sions: conformer MGBG 21 versus MGBG 22 and MGBG
23 (Figs. 1, 2).
Aquation of MGBG, considering a solvent continuum
model plus two explicit water molecules, involves forma-
tion of specific hydrogen close contacts between the
positively charged terminal amino groups of MGBG and
H2O. These are predicted by the calculations to be quite
strong: (H)OH(N) distances of 151 and 152 pm, and
(O31H3N2) and (O28H15N14) angles of ca. 170 (Fig. 1).
Apart from diprotonated MGBG, the monoprotonated
(HMGBG) and unprotonated (neutral) forms of the mole-
cule were also investigated as to their conformational
preferences. Figure 4 comprises the most stable structures
calculated for each of these species, in aqueous solution. In
fact, the monocationic geometry MGBG 11 is expected to
be present at physiological conditions along with the
predominant diprotonated species MGBG 21 (Fig. 3), its
relative populations (ca. 60:40%) being determined by the
amine pKa values of the molecule. Moreover, the very high
dipole moment of the monoprotonated conformer MGBG
11 (l = 17.2 D) can favour its occurrence at physiological
conditions (polar medium).
Biological activity
The results presently reported refer to particular biological
mechanisms associated to MGBG, such as its transport
across the plasma and mitochondrial membranes and the
prevention of the MPT process. Most probably these events
involve different MGBG structures, thus evidencing the
importance of their exact knowledge.
As represented in Fig. 5, at the exogenous concentration
of 50 lM MGBG is taken up by an hepatocyte culture at
about 50 pmol/mg prot., for a 100 min incubation time.
This uptake is completely insensitive to the presence
of ouabain, while the uncoupler carbonyl cyanide-
p-trifluorometoxyphenylhydrazone (FCCP) exhibits an
inhibition of about 50%. For comparison purposes, Fig. 5
also displays the transport of the biogenic amine agmatine.
For a concentration of 50 lM, agmatine is shown to be
taken up by hepatocytes at about 40 pmol/mg prot. Also in
Fig. 3 Schematic representation of the calculated major physiolog-
ical species of MGBG (MGBG 21) and agmatine (AGM 22 [14C])
Fig. 4 Schematic representation of the calculated lowest energy
conformers for monoprotonated (MGBG 11) and unprotonated
(MGBG 01) MGBG, in aqueous solution (The values of the
corresponding total dipole moments are included)
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this case ouabain is ineffective, whereas FCCP induces an
inhibition of about 50%. The choice of agmatine for
comparison purposes is due to the structural similarity
between this amine and MGBG.
Figure 6 depicts the transport of MGBG, at a 1 mM
exogenous concentration, in RLM energised by succinate
oxidation, in the presence of rotenone (in order to favour
substrate oxidation) and phosphate (to obtain a very high
DW, Fig. 6, inset). MGBG transport is compared with that
of agmatine, the mechanism of which has recently been
characterised (Salvi et al. 2006; Agostinelli et al. 2007),
and with that of spermidine, also previously reported
(Toninello et al. 1992) (also for a 1 mM concentration). It
is verified that MGBG is transported at about 85 nmol/mg
prot, for a 20 min incubation period, a higher extent than
that measured for either agmatine (&70 nmol/mg prot.) or
spermidine (&45 nmol/mg prot.). In the presence of
FCCP, which collapses DW (Fig. 6, inset), all these trans-
port processes are almost completely inhibited,
demonstrating a clear mechanistic difference relative to the
transport mechanism across the plasma membrane (Fig. 5).
The decrease of about 1unit in the apparent absorbance
(at 540 nm) of the mitochondrial suspension is plotted in
Fig. 7, which is indicative of mitochondrial swelling,
induced by 50 lM Ca2+ in the presence of phosphate.
The total inhibition observed in the presence of the
immunosuppressant cyclosporin A (CsA) demonstrates that
this absorbance change is due to the opening of the tran-
sition pore, related to MPT induction (for a review see
Zoratti and Szabo` 1995). If RLM are incubated with of
1 mM MGBG, mitochondrial swelling is completely
FCCP
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Fig. 5 Time course of MGBG and agmatine uptake by an hepatocyte
culture. Hepatocytes were incubated at 37C (as described in the
Experimental Section), in the presence of 50 lM-[14C]MGBG
(1 lCi/ml) (solid lines) or 50 lM-[14C]agmatine (1 lCi/ml) (dashed
lines). Where indicated, 5 lM-FCCP or 0.15 mM-ouabain were
added (Mean values ± SD of five independent experiments)
FCCP
Time (min)
50
40
60
80
100
20
M
G
BG
 (  
    
), a
gm
ati
ne
  ( 
    
 ), 
sp
er
mi
din
e (
    
  ) 
up
tak
e (
pm
ol/
mg
 of
 pr
ote
in)
10 15 20
FCCP
Pi
0
180
Fig. 6 Time-course of MGBG, agmatine and spermidine uptake by
isolated RLM, showing the dependence on the mitochondria energ-
ised state. RLM were incubated in standard medium (as described in
the Experimental Section), in the presence of 1 mM-phosphate (Pi)
with 1 mM-[14C]MGBG (1 lCi/ml) (solid lines), 1 mM-[14C]agma-
tine (1 lCi/ml) (dashed lines) or 1 mM-[14C]spermidine (1 lCi/ml)
(dotted lines). Where indicated, 1 lM-FCCP was added. Inset DW
measurement of RLM with and without phosphate. De-energisation
by FCCP (Mean values ± SD of five independent experiments)
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Fig. 7 Inhibition of Ca2+-induced mitochondrial permeability transi-
tion by MGBG and carnitine. RLM were incubated in standard
medium (as described in the Experimental Section), in the presence of
1 mM-Pi and 50 lM-Ca2+. Where indicated 1 mM-MGBG, 1 mM-
carnitine or 1 lM-CsA were added (Five independent experiments
yielded almost identical results)
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prevented (Fig. 7), which also occurs for agmatine and
spermidine for the same MGBG dosage (results available
from the authors upon request). Incubation of RLM with
1 mM carnitine, in turn, results in a strong but not complete
inhibition of the swelling.
The results presently obtained lead to the characterisa-
tion of the most stable physiological MGBG structures.
Furthermore, this work also aims at establishing the
MGBG geometry (or geometries) able to cross the plasma
and mitochondrial membranes, and to interact with dif-
ferent macromolecular structures in vivo, leading to the
known MGBG antitumoural effect.
According to the molecule’s pKa values (7.5 and 9.2),
both the mono- and diprotonated forms of the molecule are
present under physiological pH (ca. 60:40%). Among the
five diprotonated structures calculated as conformational
minima for MGBG, the most stable and largely predomi-
nant one is MGBG 21, with a relative population of 95.7%
and a total dipole moment of 1.3 D. However, as men-
tioned above, at neutral pH a significant fraction of
monoprotonated form also occurs. Consequently, in the
light of the theoretical data presently gathered, MGBG 21
(l = 1.3 D) and MGBG 11 (l = 17.2 D) (Figs. 3, 4) are
proposed to be the main MGBG species in biological fluids
and inner cell compartments of MGBG-treated patients.
A large number of reports are to be found in the liter-
ature on the MGBG transport across the plasma membrane
of different cells (for a review see William-Ashman and
Seidenfeld 1986), and several authors refer that MGBG
shares the same transporter with biogenic polyamines. It is
also possible that this drug uses the monoamine trans-
porters EMT and OCT2, which are involved in the uptake
of agmatine (Cabella et al. 2001). Actually, since agmatine
is a divalent cation at pH 7.4, comprising a guanidinium
group, similarly to MGBG (Fig. 3), this hypothesis should
not be disregarded. Moreover, MGBG could be transported
in the unprotonated, uncharged form, since those trans-
porters exhibit an electroneutral behaviour (Grundemann
et al. 2003).
The results represented in Fig. 5 confirm this hypothe-
sis. As previously demonstrated (Cabella et al. 2001),
agmatine is transported in hepatocytes by an energy-
dependent mechanism, as ouabain, a plasma membrane de-
energising agent (Clausen and Flatman 1977) proved to be
an ineffective inhibitor of this process. In addition, FCCP,
which collapses the electrochemical gradient of ‘‘in situ’’
mitochondria, exhibits a partial inhibition of agmatine
transport, as it only excludes the entrance of the amine in
the mitochondrial matrix. This data clearly shows that
agmatine is transported through an electroneutral mecha-
nism in hepatocyte cultures, supporting the statement that
the unprotonated species is involved in this process as
observed for EMT and OCT2 transporters (Grundemann
et al. 2003). Figure 5 also shows that MGBG is transported
in hepatocytes, even to a larger extent than agmatine,
suggesting that the presence of two guanidinium groups in
its molecule further favours this mechanism. The absence
of the ouabain effect and the partial inhibition by FCCP
confirm that MGBG is taken up in the uncharged form.
In addition, MGBG is known to cross the mitochondrial
membrane: Byczkowski and coworkers (Byczkowski et al.
1981; Byczkowski and Porter 1983) reported that MGBG is
taken up by RLM when incubated in energised media,
while Diwan et al. (1988) observed an enhancement of
MGBG transport in RLM submitted to outer membrane
lysis. These observations are confirmed by the results
shown in Fig. 6, in different media, in order to establish
high DW values (of about 180 mV, Fig. 6, inset) and
induce MGBG transport to a higher extent (Byczkowski
et al. 1981; Byczkowski and Porter 1983; Diwan et al.
1988). Comparison with agmatine and spermidine transport
processes clearly evidences the significance of the presence
of two guanidinium groups in the MGBG molecule, which
leads to a larger transport extent in mitochondria relative to
both agmatine (one guanidinium) and spermidine (one
amino-butyl and one amino-propyl group). The decrease in
spermidine transport as compared to agmatine and MGBG
is due to its lower dipole moment at physiological pH
(l = 2.76 D), (M. P. M. Marques, unpublished results)
despite its higher charge (3+) (Toninello et al. 1992a, b),
emphasising the importance of this parameter for polyca-
tion transport in mitochondria. Recently, it was
demonstrated that agmatine is carried through the mito-
chondrial membrane using a channel or a single-binding
centre-gated pore exhibiting an electrophoretic behaviour
(Salvi et al. 2006; Agostinelli et al. 2007). Agmatine is
proposed to cross the mitochondrial membrane in the
monoprotonated form, due its high polarity and the sig-
nificant DW at the mitochondrial surface. On the basis of
these previous results for a similar polyamine, and con-
sidering the very high dipole moment of monoprotonated
MGBG 11 (l = 17.2 D, even higher than that of mono-
valent agmatine, l = 15.8 D), it is suggested that MGBG is
transported in mitochondria in the MGBG 11 conforma-
tion. Moreover, a slight amount of MGBG may also be
transported as a divalent cation, in the MGBG 24 form,
since this geometry has a dipole moment of 9.5 D, much
higher than that of the predominant dipositive species
MGBG 21 (Table 1).
Interaction of MGBG with the macromolecules within
the cell, in order to exert its biological functions, is strongly
dependent on its conformational behaviour. The drug is
expected to interact with the biomolecular structures by
means of weak interactions—hydrogen bonds, Van der
Walls forces, cation/p interactions, electrostatic close-
contacts between hydrated charged groups, etc.—as
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verified for biogenic polyamines (Dalla Via et al. 1985,
1999). Due to the p-resonance occurring in the guanidi-
nium groups, MGBG has a quite rigid structure, surely not
as flexible as that of spermine or even spermidine (Toni-
nello et al. 1999). This implies that MGBG will only bind
to particular biological sites. A very important observation
arose from a study on MGBG inhibition of carnitine pal-
mitoyl transferase (Brady et al. 1987): the guanidinium
moiety was found to occupy the quaternary ammonium site
of carnitine, thus suggesting that an anionic group should
be located in the active site for an effective interaction with
the amine to occur. Indeed, the same work reports that the
MGBG chain extends with that of acylcarnitine, allowing
an immino group from MGBG to occupy a position similar
to the acyl carbonyl, enabling the formation of a thiola-
minal with a thiol at the active site, by substituting the
normal interaction of the acyl carbonyl with the SH group.
This type of observations reveals a tight conformational
accordance between MGBG and its biological receptors,
the sites of interaction being required to display a particular
architecture for the binding to be efficient. This is very
surprisingly confirmed by the observation that carnitine,
although with a lesser efficacy as compared to MGBG, is
also able to inhibit MPT (Fig. 7) (see also Di Lisa et al.
1985), suggesting that the critical binding site responsible
for MPT inhibition by both MGBG and carnitine has an
identical geometry to that of the active site of carnitine
palmitoyl tranferase. MGBG does not easily bind to an
anionic group and needs a particular receptor, with a well-
defined geometry. This fact was previously discussed by
William-Ashman and collaborators (1986), who, however,
ascribed it to the low electrical charge of the molecule. The
present work denies this hypothesis, since it proves that
MGBG occurs predominantly in a positively charged form
in the physiological medium.
From the presently obtained MGBG structural data, the
mono- and diprotonated species of the molecule are the
ones proposed to be involved in the drug’s interaction with
its biological targets. Although both H2MGBG (MGBG 21)
and HMGBG (MGBG 11) are present at physiological
conditions, the requirement for charged guanidinium
groups for the drug-receptor interplay to occur renders the
diprotonated form the most effective.
The structural study now performed for MGBG in
aqueous solution, as a function of its protonation degree,
allows a thorough characterisation of the most stable
geometries of the molecule at physiological conditions.
Since the activity of this kind of systems (e.g. biogenic
polyamines) is known to be ruled by their structural pref-
erences, the knowledge of the conformational behaviour of
MGBG is essential for the understanding of its biological
role, namely its effect on enzyme activity, polyamine
transport and MPT induction. As to the latter, the opening
of the transition pore is proposed to be strictly related to
programmed cell death and, consequently to all patholog-
ical processes linked to apoptosis.
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